Impact of the COVID-19 pandemic on hospitalizations of patients with moderate-to-severe skin diseases: A retrospective cohort analysis from a Central European Center - 09/12/21
Key words : dermatology, health services utilization, rare diseases, SARS-CoV-2, skin cancer
Funding sources: FS and DK are supported by the Berta-Ottenstein Advanced Clinician Scientist Programme of the University of Freiburg. DK is supported by theGerman Research Foundation (DFG) through SFB1160 project B03 and KI1795/2-1, as well as the Fritz Thyssen Foundation. |
|
IRB approval status: No 21-147 of Freiburg Ethics Committee Board and study registration on the German Clinical Trials Register (www.drks.de, DRKS-ID DRKS000244633). |
|
Reprints not available from the authors. |
Vol 86 - N° 1
P. 245-248 - janvier 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.